Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO2 laser plus Wharton's jelly stem cell-derived conditioned medium for resistant hand atopic eczema
IRCT20200127046282N57Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2025
- Countries
- 1
01
Overview
Phase 2, single-blind trial of platelet-rich plasma in atopic dermatitis (AD) and hand dermatitis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Reduction or improvement of hand eczema. Started Nov 2025; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
atopic dermatitis (AD)hand dermatitis
Beyond the preview
Go deeper on IRCT20200127046282N57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200127046282N57.